165 related articles for article (PubMed ID: 12161475)
21. Clinical, Ovulatory and Histological Effect of a Postnatal Testosterone Treatment in Female Dogs.
Marchetti C; Grisolia-Romero M; Priotto M; Faya M; Gobello C
Animals (Basel); 2024 Mar; 14(7):. PubMed ID: 38612288
[TBL] [Abstract][Full Text] [Related]
22. Fabrication of silastic testosterone enanthate implants to achieve virilizing levels of serum testosterone in swine.
Mahabir N; Newell-Fugate AE
MethodsX; 2024 Jun; 12():102549. PubMed ID: 38283761
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of Transdermal Dihydrotestosterone and Testosterone Enanthate for Penile Augmentation in Patients With Idiopathic Micropenis: A Comparative Randomized Study.
Karrou M; Messaoudi N; Assarrar I; Alla A; Rouf S; Latrech H
Clin Med Insights Endocrinol Diabetes; 2023; 16():11795514231208328. PubMed ID: 37920173
[TBL] [Abstract][Full Text] [Related]
24. Male contraception: where are we going and where have we been?
Reynolds-Wright JJ; Anderson R
BMJ Sex Reprod Health; 2019 Sep; 45(4):236-42. PubMed ID: 31537614
[TBL] [Abstract][Full Text] [Related]
25. Steroid hormones for contraception in men.
Grimes DA; Lopez LM; Gallo MF; Halpern V; Nanda K; Schulz KF
Cochrane Database Syst Rev; 2012 Mar; (3):CD004316. PubMed ID: 22419294
[TBL] [Abstract][Full Text] [Related]
26. A new combination of testosterone and nestorone transdermal gels for male hormonal contraception.
Ilani N; Roth MY; Amory JK; Swerdloff RS; Dart C; Page ST; Bremner WJ; Sitruk-Ware R; Kumar N; Blithe DL; Wang C
J Clin Endocrinol Metab; 2012 Oct; 97(10):3476-86. PubMed ID: 22791756
[TBL] [Abstract][Full Text] [Related]
27. Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach.
Bebb RA; Anawalt BD; Christensen RB; Paulsen CA; Bremner WJ; Matsumoto AM
J Clin Endocrinol Metab; 1996 Feb; 81(2):757-62. PubMed ID: 8636300
[TBL] [Abstract][Full Text] [Related]
28. Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis.
Liu PY; Swerdloff RS; Christenson PD; Handelsman DJ; Wang C;
Lancet; 2006 Apr; 367(9520):1412-20. PubMed ID: 16650651
[TBL] [Abstract][Full Text] [Related]
29. Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant.
Ali M; Akin A; Bahamondes L; Brache V; Habib N; Landoulsi S; Hubacher D;
Hum Reprod; 2016 Nov; 31(11):2491-2498. PubMed ID: 27671673
[TBL] [Abstract][Full Text] [Related]
30. A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls.
Bahamondes L; Brache V; Meirik O; Ali M; Habib N; Landoulsi S;
Hum Reprod; 2015 Nov; 30(11):2527-38. PubMed ID: 26409014
[TBL] [Abstract][Full Text] [Related]
31. Effect of Implanon and Norplant subdermal contraceptive implants on serum lipids--a randomized comparative study.
Biswas A; Viegas OA; Roy AC
Contraception; 2003 Sep; 68(3):189-93. PubMed ID: 14561539
[TBL] [Abstract][Full Text] [Related]
32. Suppression of spermatogenesis by etonogestrel implants with depot testosterone: potential for long-acting male contraception.
Anderson RA; Kinniburgh D; Baird DT
J Clin Endocrinol Metab; 2002 Aug; 87(8):3640-9. PubMed ID: 12161488
[TBL] [Abstract][Full Text] [Related]
33. A multicentre study investigating subcutaneous etonogestrel implants with injectable testosterone decanoate as a potential long-acting male contraceptive.
Brady BM; Amory JK; Perheentupa A; Zitzmann M; Hay CJ; Apter D; Anderson RA; Bremner WJ; Pollanen P; Nieschlag E; Wu FC; Kersemaekers WM
Hum Reprod; 2006 Jan; 21(1):285-94. PubMed ID: 16172147
[TBL] [Abstract][Full Text] [Related]
34. A clinical trial of 7 alpha-methyl-19-nortestosterone implants for possible use as a long-acting contraceptive for men.
von Eckardstein S; Noe G; Brache V; Nieschlag E; Croxatto H; Alvarez F; Moo-Young A; Sivin I; Kumar N; Small M; Sundaram K;
J Clin Endocrinol Metab; 2003 Nov; 88(11):5232-9. PubMed ID: 14602755
[TBL] [Abstract][Full Text] [Related]
35. Male hormonal contraception: effects of injections of testosterone undecanoate and depot medroxyprogesterone acetate at eight-week intervals in chinese men.
Gu YQ; Tong JS; Ma DZ; Wang XH; Yuan D; Tang WH; Bremner WJ
J Clin Endocrinol Metab; 2004 May; 89(5):2254-62. PubMed ID: 15126550
[TBL] [Abstract][Full Text] [Related]
36. transient scrotal hyperthermia and levonorgestrel enhance testosterone-induced spermatogenesis suppression in men through increased germ cell apoptosis.
Wang C; Cui YG; Wang XH; Jia Y; Sinha Hikim A; Lue YH; Tong JS; Qian LX; Sha JH; Zhou ZM; Hull L; Leung A; Swerdloff RS
J Clin Endocrinol Metab; 2007 Aug; 92(8):3292-304. PubMed ID: 17504903
[TBL] [Abstract][Full Text] [Related]
37. 7alpha-methyl-19-nortestosterone (MENT) vs testosterone in combination with etonogestrel implants for spermatogenic suppression in healthy men.
Walton MJ; Kumar N; Baird DT; Ludlow H; Anderson RA
J Androl; 2007; 28(5):679-88. PubMed ID: 17460095
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of testosterone undecanoate injected alone or in combination with norethisterone enanthate in healthy men.
Qoubaitary A; Meriggiola C; Ng CM; Lumbreras L; Cerpolini S; Pelusi G; Christensen PD; Hull L; Swerdloff RS; Wang C
J Androl; 2006; 27(6):853-67. PubMed ID: 16837736
[TBL] [Abstract][Full Text] [Related]
39. Novel male hormonal contraceptive combinations: the hormonal and spermatogenic effects of testosterone and levonorgestrel combined with a 5alpha-reductase inhibitor or gonadotropin-releasing hormone antagonist.
Matthiesson KL; Amory JK; Berger R; Ugoni A; McLachlan RI; Bremner WJ
J Clin Endocrinol Metab; 2005 Jan; 90(1):91-7. PubMed ID: 15509637
[TBL] [Abstract][Full Text] [Related]
40. Intratesticular testosterone concentrations comparable with serum levels are not sufficient to maintain normal sperm production in men receiving a hormonal contraceptive regimen.
Coviello AD; Bremner WJ; Matsumoto AM; Herbst KL; Amory JK; Anawalt BD; Yan X; Brown TR; Wright WW; Zirkin BR; Jarow JP
J Androl; 2004; 25(6):931-8. PubMed ID: 15477366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
